201 related articles for article (PubMed ID: 32347970)
1. The association between serum albumin/prealbumin level and disease severity in non-CF bronchiectasis.
Li L; Li Z; Bi J; Li H; Wang S; Shao C; Song Y
Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1537-1544. PubMed ID: 32347970
[TBL] [Abstract][Full Text] [Related]
2. Serum Albumin and Disease Severity of Non-Cystic Fibrosis Bronchiectasis.
Lee SJ; Kim HJ; Kim JY; Ju S; Lim S; Yoo JW; Nam SJ; Lee GD; Cho HS; Kim RB; Cho YJ; Jeong YY; Kim HC; Lee JD
Respir Care; 2017 Aug; 62(8):1075-1084. PubMed ID: 28512120
[TBL] [Abstract][Full Text] [Related]
3. Predicting mortality in non-cystic fibrosis bronchiectasis patients using distance-saturation product.
Lin CY; Hsieh MH; Fang YF; Peng CW; Ju JS; Lo YL; Lin SM; Lin HC
Ann Med; 2021 Dec; 53(1):2034-2040. PubMed ID: 34761709
[TBL] [Abstract][Full Text] [Related]
4. Serum hepatocyte growth factor as a predictor of disease severity and future exacerbations in patients with non-cystic fibrosis bronchiectasis.
Jeong JH; Heo M; Kim EJ; Hah YS; Heo IR; Kim TH; Kim HC; Ju S; Yoo JW; Jeong YY; Lee JD; Lee SJ
Respir Med; 2021; 185():106505. PubMed ID: 34139579
[TBL] [Abstract][Full Text] [Related]
5. Hiatal hernias are correlated with increased severity of non-cystic fibrosis bronchiectasis.
McDonnell MJ; Ahmed M; Das J; Ward C; Mokoka M; Breen DP; O'Regan A; Gilmartin JJ; Bruzzi J; Rutherford RM
Respirology; 2015 Jul; 20(5):749-57. PubMed ID: 25872951
[TBL] [Abstract][Full Text] [Related]
6. Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts.
McDonnell MJ; Aliberti S; Goeminne PC; Dimakou K; Zucchetti SC; Davidson J; Ward C; Laffey JG; Finch S; Pesci A; Dupont LJ; Fardon TC; Skrbic D; Obradovic D; Cowman S; Loebinger MR; Rutherford RM; De Soyza A; Chalmers JD
Thorax; 2016 Dec; 71(12):1110-1118. PubMed ID: 27516225
[TBL] [Abstract][Full Text] [Related]
7. Which scoring system is better in association with exercise capacity and health status in noncystic fibrosis bronchiectasis patients?
Varol Y; Doğan Şahin H; Aksel N; Çırak AK
Turk J Med Sci; 2021 Apr; 51(2):631-637. PubMed ID: 33081435
[TBL] [Abstract][Full Text] [Related]
8. Aetiology and disease severity are among the determinants of quality of life in bronchiectasis.
Terpstra LC; Biesenbeek S; Altenburg J; Boersma WG
Clin Respir J; 2019 Aug; 13(8):521-529. PubMed ID: 31295770
[TBL] [Abstract][Full Text] [Related]
9. Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study.
Brill SE; Patel AR; Singh R; Mackay AJ; Brown JS; Hurst JR
Respir Res; 2015 Feb; 16(1):16. PubMed ID: 25849856
[TBL] [Abstract][Full Text] [Related]
10. Validation of a visual analogue score (LRTI-VAS) in non-CF bronchiectasis.
Altenburg J; Wortel K; de Graaff CS; van der Werf TS; Boersma WG
Clin Respir J; 2016 Mar; 10(2):168-75. PubMed ID: 25103370
[TBL] [Abstract][Full Text] [Related]
11. The Bronchiectasis Severity Index and FACED score for assessment of the severity of bronchiectasis.
Costa JC; Machado JN; Ferreira C; Gama J; Rodrigues C
Pulmonology; 2018 Jan; ():. PubMed ID: 29306672
[TBL] [Abstract][Full Text] [Related]
12. Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.
Paredes Aller S; Quittner AL; Salathe MA; Schmid A
Expert Rev Respir Med; 2018 Sep; 12(9):769-782. PubMed ID: 30025482
[TBL] [Abstract][Full Text] [Related]
13. COPD Assessment Test (CAT) is a Valid and Simple Tool to Measure the Impact of Bronchiectasis on Affected Patients.
Lanza FC; Castro RAS; de Camargo AA; Zanatta DJM; Rached S; Athanazio R; Cukier A; Stelmach R; Dal Corso S
COPD; 2018 Oct; 15(5):512-519. PubMed ID: 30468091
[TBL] [Abstract][Full Text] [Related]
14. Validation of the COPD Assessment Test (CAT) as an Outcome Measure in Bronchiectasis.
Finch S; Laska IF; Abo-Leyah H; Fardon TC; Chalmers JD
Chest; 2020 Apr; 157(4):815-823. PubMed ID: 31730832
[TBL] [Abstract][Full Text] [Related]
15. Validity and Reliability of the Chronic Respiratory Disease Questionnaire in Elderly Individuals with Mild to Moderate Non-Cystic Fibrosis Bronchiectasis.
Vodanovich DA; Bicknell TJ; Holland AE; Hill CJ; Cecins N; Jenkins S; McDonald CF; Burge AT; Thompson P; Stirling RG; Lee AL
Respiration; 2015; 90(2):89-96. PubMed ID: 26088151
[TBL] [Abstract][Full Text] [Related]
16. Serum albumin is a predictor of respiratory hospitalization in patients with bronchiectasis.
Ju S; Jeong JH; Heo M; Heo IR; Kim TH; Kim HC; Yoo JW; Cho YJ; Jeong YY; Lee JD; Lee SJ
Chron Respir Dis; 2021; 18():14799731211017548. PubMed ID: 34032131
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors in Adult Patients with Non-Cystic Fibrosis Bronchiectasis.
Machado BC; Jacques PS; Penteado LP; Roth Dalcin PT
Lung; 2018 Dec; 196(6):691-697. PubMed ID: 30255201
[TBL] [Abstract][Full Text] [Related]
18. Serum Fibrinogen as a Biomarker for Disease Severity and Exacerbation in Patients with Non-Cystic Fibrosis Bronchiectasis.
Lee SJ; Jeong JH; Heo M; Ju S; Yoo JW; Jeong YY; Lee JD
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887712
[No Abstract] [Full Text] [Related]
19. Quantitative computed tomography features and clinical manifestations associated with the extent of bronchiectasis in patients with moderate-to-severe COPD.
Bak SH; Kim S; Hong Y; Heo J; Lim MN; Kim WJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():1421-1431. PubMed ID: 29750028
[TBL] [Abstract][Full Text] [Related]
20. 25-Hydroxy vitamin D and body composition are associated with pulmonary function in non-cystic fibrosis bronchiectasis: A cross-sectional study.
Sami R; Zohal M; Marhamati KHamene A; Rajabi S; Shokri-Mashhadi N
Clin Nutr ESPEN; 2021 Dec; 46():527-531. PubMed ID: 34857245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
